Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state

The Journal of Biological Chemistry
Z E SaunaS V Ambudkar

Abstract

Multidrug resistance protein 4 (MRP4/ABCC4), transports cyclic nucleoside monophosphates, nucleoside analog drugs, chemotherapeutic agents, and prostaglandins. In this study we characterize ATP hydrolysis by human MRP4 expressed in insect cells. MRP4 hydrolyzes ATP (Km, 0.62 mm), which is inhibited by orthovanadate and beryllium fluoride. However, unlike ATPase activity of P-glycoprotein, which is equally sensitive to both inhibitors, MRP4-ATPase is more sensitive to beryllium fluoride than to orthovanadate. 8-Azido[alpha-32P]ATP binds to MRP4 (concentration for half-maximal binding approximately 3 microm) and is displaced by ATP or by its non-hydrolyzable analog AMPPNP (concentrations for half-maximal inhibition of 13.3 and 308 microm). MRP4 substrates, the prostaglandins E1 and E2, stimulate ATP hydrolysis 2- to 3-fold but do not affect the Km for ATP. Several other substrates, azidothymidine, 9-(2-phosphonylmethoxyethyl)adenine, and methotrexate do not stimulate ATP hydrolysis but inhibit prostaglandin E2-stimulated ATP hydrolysis. Although both post-hydrolysis transition states MRP4.8-azido[alpha-32P]ADP.Vi and MRP4.8-azido[alpha-32P]ADP.beryllium fluoride can be generated, nucleotide trapping is approximately 4-fold higher...Continue Reading

References

Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S V AmbudkarI Pastan
Dec 1, 1973·Analytical Biochemistry·W Schaffner, C Weissmann
Nov 10, 1995·The Journal of Biological Chemistry·I L UrbatschA E Senior
Aug 18, 1995·The Journal of Biological Chemistry·I L UrbatschA E Senior
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Dec 27, 1995·FEBS Letters·A E SeniorI L Urbatsch
Jun 3, 1997·Biochemistry·B SankaranA E Senior
Jan 10, 1998·The Journal of Biological Chemistry·X B ChangJ R Riordan
May 23, 1998·Annual Review of Pharmacology and Toxicology·J R VaneR M Botting
Nov 27, 1998·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J R Vane, R M Botting
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
May 29, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J Chick
Oct 21, 1999·Biochemistry·C A HrycynaM M Gottesman
Dec 3, 1999·Biochimica Et Biophysica Acta·P BorstJ Wijnholds
Mar 10, 2000·FEBS Letters·J H HooijbergH J Broxterman
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z E Sauna, S V Ambudkar
Jun 8, 2000·Journal of the National Cancer Institute·T W Loo, D M Clarke
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Dec 7, 2000·Journal of the National Cancer Institute·K LeeG D Kruh
Mar 30, 2001·The Journal of Biological Chemistry·H ShengR N DuBois
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·Z E SaunaS V Ambudkar
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·G D KruhM G Belinsky
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tip W Loo, David M Clarke
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tapan K BeraIra Pastan
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink

❮ Previous
Next ❯

Citations

Jul 16, 2005·Cancer Chemotherapy and Pharmacology·Wanida ChearwaePornngarm Limtrakul
Feb 23, 2010·Nature Structural & Molecular Biology·Oded LewinsonDouglas C Rees
May 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Chitra A ShintreElisabeth P Carpenter
Jul 2, 2009·Clinical and Experimental Pharmacology & Physiology·Ya-He LiuShu-Feng Zhou
Oct 23, 2012·Cancer Research·Ekaterina V MalofeevaElizabeth A Hopper-Borge
Nov 22, 2011·Chinese Journal of Cancer·Kamlesh SodaniZhe-Sheng Chen
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Christoph O Randak, Michael J Welsh
Mar 8, 2012·Expert Opinion on Drug Metabolism & Toxicology·Péter KrajcsiIstván Sziráki
Jun 24, 2015·Critical Reviews in Oncology/hematology·M P WeenC Ricciardelli
Mar 23, 2015·Ageing Research Reviews·Maria João GomesBruno Sarmento
Aug 6, 2019·SLAS Discovery·David HardyAlice J Rothnie
Jul 8, 2015·The Journal of Pharmacology and Experimental Therapeutics·Jiagen WenWei Zhang
Nov 27, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shipeng WeiKevin L Kirk
Jun 15, 2013·The Journal of Biological Chemistry·Satish B CheepalaJohn D Schuetz
May 15, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Isabelle J LétourneauSusan P C Cole
Aug 20, 2019·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Nobuaki TanakaNariyasu Mano
Dec 15, 2005·The Journal of Biological Chemistry·Da-Wei ZhangHelen H Hobbs
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Edgardo BecerraGuadalupe García-Alcocer
Oct 15, 2021·The Journal of General Physiology·Daniel T InfieldNael A McCarty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.